Kreos Capital
Kreos Capital is a leading provider of growth and venture debt financing to high-growth companies in the technology and healthcare sectors across Europe and Israel. With over 25 years of experience, Kreos offers innovative and flexible debt solutions to support companies through every stage of their growth lifecycle, from entry to late-stage growth including pre and post-IPO. The company has committed more than €5.7 billion in over 750 transactions, supporting a diverse portfolio of high-growth businesses. Kreos Capital emphasizes responsible investment, ESG principles, and sustainability, continuously improving its practices and integrating ESG considerations into its operations and investment processes.
Industries
Nr. of Employees
small (1-50)
Kreos Capital
25 Old Burlington Street, London W1S 3AN, United Kingdom
Patents
Pleuromutilin derivatives for the treatment of diseases mediated by microbes
US-8153689-B2
View DetailsPleuromutilin derivatives for the treatment of diseases mediated by microbes
US-8071643-B2
View Details
Pleuromutilin derivatives for the treatment of diseases mediated by microbes
US-8153689-B2
View DetailsPleuromutilin derivatives for the treatment of diseases mediated by microbes
US-8071643-B2
View DetailsServices
Structured debt facilities for equity-backed, high-growth companies across stages from early growth to pre- and post-IPO.
End-to-end deal support including sourcing, credit assessment, transaction structuring, negotiation and closing.
Ongoing portfolio monitoring, quantitative performance analytics and modelling to support investment oversight and reporting.
Integrated commercial, financial and sustainability due diligence using sustainability questionnaires and restricted investment lists, with committee-based approval processes.
Compliance management, policy development and governance oversight for funds and investment activities.
Origination and investment support across multiple jurisdictions with a focus on European and Israeli markets, combining local presence with international coverage.
Structured debt facilities for equity-backed, high-growth companies across stages from early growth to pre- and post-IPO.
End-to-end deal support including sourcing, credit assessment, transaction structuring, negotiation and closing.
Ongoing portfolio monitoring, quantitative performance analytics and modelling to support investment oversight and reporting.
Integrated commercial, financial and sustainability due diligence using sustainability questionnaires and restricted investment lists, with committee-based approval processes.
Compliance management, policy development and governance oversight for funds and investment activities.
Origination and investment support across multiple jurisdictions with a focus on European and Israeli markets, combining local presence with international coverage.
Expertise Areas
- Growth and venture debt financing
- Technology sector financing
- Healthcare sector financing
- Portfolio management and performance analytics
Key Technologies
- Performance analytics
- Portfolio modelling tools
- Data analytics
- Cloud-based systems
News & Updates
BlackRock Inc. announced the completion of its acquisition of Kreos, a leading provider of growth and venture debt financing to companies in the technology and healthcare industries.
BlackRock accelerates growth of its Credit platform with the acquisition of Kreos, providing clients with access to growth and venture debt strategies.
UK’s fastest-growing food or beverage brand, THIS™, launches its popular product into the frozen food range.
BlackRock Inc. announced the completion of its acquisition of Kreos, a leading provider of growth and venture debt financing to companies in the technology and healthcare industries.
BlackRock accelerates growth of its Credit platform with the acquisition of Kreos, providing clients with access to growth and venture debt strategies.
UK’s fastest-growing food or beverage brand, THIS™, launches its popular product into the frozen food range.